For older adults, getting vaccinated provides protection against COVID-19, but getting a booster is a key part of maintaining that immunity, a new study confirms. “The data support the CDC guidelines for COVID-19 vaccination and affirm that the vaccine is initially able to mount a good antibody response,” said study co-author Dr. Sean Leng. He’s…  read on >  read on >

Birth control pills that contain both estrogen and progestin do not contribute to growth of enlarged breasts in teens and young women, a new study finds, and may actually be associated with developing less severe breast enlargement. Moreover, the combination pills don’t increase the risk of regrowth after breast-reduction surgery, said researcher Dr. Brian Labow…  read on >  read on >

Sometimes that irritated skin on your hands is more than simple dryness. Hand eczema could be the culprit, with painful dry and itchy skin on all or part of the hand and fingers. “If your hands are extremely dry and painful, and using moisturizer throughout the day is not helping to relieve them, you may…  read on >  read on >

Allergy sufferers know that symptoms don’t just appear in spring or summer. Fall, too, can bring about sneezing and trouble breathing, as can volatile weather patterns. “People frequently experience allergy symptoms in the fall even if they are mainly allergic to pollens in the spring and summer,” said Dr. David Corry. He is a professor…  read on >  read on >

The U.S. government will invest $266 million to shore up the community and public health workforce using American Rescue Plan funding. About $225.5 million will go to 83 recipients to support training and apprenticeship for 13,000 new community health workers, CNN reported before Friday’s announcement. These workers specialize in helping people find care and serve…  read on >  read on >

FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease. But approval of the drug, called Relyvrio, is bound to stir new questions, with some doubting the strength of data supporting its…  read on >  read on >